Novan Seeks to Unleash Power of Nitric Oxide in 'Tunable' Drugs

February 10, 2014

For nearly two decades, scientists have appreciated the healing power of nitric oxide (NO), a free radical that garnered researchers at three U.S. institutions the 1998 Nobel Prize in Physiology or Medicine for their discoveries involving NO as a signaling molecule in the cardiovascular system. 

Full Story

Industry Report: New Players Emerge as Consolidation Continues

December, 2013

The changing industry landscape opens space for new players and novel approaches, as well-known leaders continue to evolve.

Full Story

Durham Drug Company Novan Awarded $7.8 Million Government Contract

August 26, 2013

Novan Therapeutics, a Durham company that is developing nitric oxide-based skin therapies, has been awarded a $7.8 million government contract to develop a treatment for thermal burns.

Full Story

Cree Co-Founder Shares Startup Wisdom

Friday, April 12, 2013

What makes a successful startup?

A platform technology. That’s according to a chat I had with Neal Hunter, co-founder of Cree (Nasdaq: CREE), who also serves as the board chair of Durham-based Novan Therapeutics, which I wrote about in this week’s print edition.

Full Story